Risk and special populations

Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic

32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock

Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak

HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

other pharmacology

Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic

indoor livin ppl

no sunlight no vitamin d

Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations

32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?

32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity

32357998 2020. Cardiac considerations in patients with COVID-19

32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty

32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times

32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers

32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease

32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV

32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China

32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment

32232395 ä. Initial COVID-19 affecting cardiac patients in China

32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?

32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19

32222253 2020. COVID-19: lessons from the Italian reproductive medical experience

32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients

32244059 ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
32302703 ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32292696 ä. COVID-19 Infection Unmasking Brugada Syndrome

32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?

32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?

32335339 ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count

32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?

32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution

32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection

32347144 2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy

32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury

32147409 ä. Are children less susceptible to COVID-19?

32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

32335512 2020. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs

32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection

32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases
32304642 ä. COVID-19 in patients with HIV: clinical case series

32224304 2020. COVID-19 infection in children

32332856 ä. COVID-19 in persons with haematological cancers

32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland

32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far

32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32372803 2020. Children and covid-19
32243722 2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection

32231171 2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis

32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19

32228252 2020. COVID-19, ACE2, and the cardiovascular consequences

32212348 2020. Why is COVID-19 so mild in children?
32339307 2020. Additional hypotheses about why COVID-19 is milder in children than adults
32279351 2020. We urgently need guidelines for managing COVID-19 in children with comorbidities
32310898 2020. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome

32311145 2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience
32243621 2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
32267016 2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)

32339251 2020. The importance of hypertension as a risk factor for severe illness and mortality in COVID-19

32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

32245656 2020. COVID-19 in patients with cardiovascular diseases

32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease

32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend

32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms

32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)

32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?

32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?

32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR

32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19

32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic

32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature

32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS

32220066 ä. SARS?CoV?2 and HIV

32160316 ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China

32347975 2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey
32343410 2020. COVID-19 in Tuberculosis patients: a report of three cases

32293709 2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better
32285949 2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19)

32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

32251539 2020. COVID-19 and liver disease

32329563 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis

32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19

32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32286926 2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
32319118 2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

32345686 2020. Vulnerable Youth and the COVID-19 Pandemic
32317311 2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children

32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
32348044 2020. L'hematologie au temps du COVID-19
32348042 2020. Infection a SARS-CoV-2 et transplantation d'organes solides

C7187739 ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa

32387456 ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)

32387167 ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
32376969 ä. COVID-19 outcomes in patients with hematologic disease

32381262 ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission

32402515 ä. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank

32388171 2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?

32389521 2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience

32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study

32376043 ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak
32380288 ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans

32376098 ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

32371279 ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports
32305569 2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support
32408961 ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery
32292915 ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support
32388230 2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
32389426 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...

32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection

32387757 2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?

32389584 ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis

Risk and special populations

Version vom 12. Juni 2020, 16:56 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge

@@ Zeile 10: / Zeile 10: @@
 '''[[RSP - Pregnancy, Neonatology]]'''
-'''[[RSP - Liver disease]'''
+'''[[RSP - Liver disease]]'''
 '''[[RSP - Diabetes, Obesity]]'''
@@ Zeile 27: / Zeile 27: @@
 '''[[RSP - Pulmonary disease]]'''
+'''[[RSP - Cystic fibrosis]]]'''
 '''[[RSP - Cardiovascular disease]]'''
 '''[[RSP - Cancer solid]]'''
@@ Zeile 48: / Zeile 48: @@
 ''' identifying factors '''
 '''Frailty'''
-{{tp|p=32268300|t=2020. Biomarkers of biological age as predictors of COVID-19 disease severity |pdf=|usr=}}
-{{tp|p=32339960|t=2020. Clinical characteristics of older patients infected with COVID-19: A descriptive  study |pdf=|usr=}}
-{{tp|p=32331795|t=ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19 |pdf=|usr=}}
-{{tp|p=32269670|t=2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults  What Do Older Adults Need To Know?|pdf=|usr=}}
@@ Zeile 136: / Zeile 131: @@
-{{tp|p=32328575|t=ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection |pdf=|usr=}}
 {{tp|p=32322805|t=ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19  in people living with HIV |pdf=|usr=}}
@@ Zeile 151: / Zeile 146: @@
 {{tp|p=32344292|t=2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |pdf=|usr=}}
-{{tp|p=32322046|t=ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China |pdf=|usr=}}
 {{tp|p=32296994|t=ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping  conditions could lead to overlapping treatments |pdf=|usr=}}
 {{tp|p=C7141546|t=ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
@@ Zeile 162: / Zeile 157: @@
 {{tp|p=32341104|t=2020. Cardiovascular comorbidity and its impact on patients with Covid-19 |pdf=|usr=}}
-{{tp|p=32312864|t=ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019 |pdf=|usr=}}
-{{tp|p=32284245|t=ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??|pdf=|usr=}}
@@ Zeile 174: / Zeile 169: @@
 {{tp|p=32323577|t=ä. What the oncologist needs to know about COVID-19 infection in cancer patients |pdf=|usr=}}
-{{tp|p=32357575|t=2020. COVID-19: A Geriatric Emergency |pdf=|usr=}}
-{{tp|p=32357582|t=2020. Ageing and COVID-19: What is the Role for Elderly People?|pdf=|usr=}}
-{{tp|p=32274617|t=2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes |pdf=|usr=}}
-{{tp|p=32199996|t=2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF |pdf=|usr=}}
 {{tp|p=32244059|t=ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes |pdf=|usr=}}
 {{tp|p=32302703|t=ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus  Disease 2019) Treatment |pdf=|usr=}}
@@ Zeile 189: / Zeile 180: @@
-{{tp|p=32342146|t=ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?|pdf=|usr=}}
-{{tp|p=32146921|t=ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in  Hong Kong and Shenzhen, China, from January 10 to February 15, 2020 |pdf=|usr=}}
@@ Zeile 203: / Zeile 190: @@
 {{tp|p=32335339|t=ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count |pdf=|usr=}}
-{{tp|p=32331343|t=2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk  of Venous Thromboembolism and Hypovitaminosis D |pdf=|usr=}}
 {{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than  males?|pdf=|usr=}}
@@ Zeile 221: / Zeile 208: @@
-{{tp|p=32305444|t=ä. COVID-19 and racial disparities |pdf=|usr=}}
 {{tp|p=32283235|t=ä. Various forms of skin rash in COVID-19 : a reply |pdf=|usr=}}
 {{tp|p=32283233|t=ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection |pdf=|usr=}}
-{{tp|p=32330545|t=ä. African American COVID-19 Mortality: A Sentinel Event |pdf=|usr=}}
-{{tp|p=32154911|t=2020. COVID?19 Presents High Risk to Older Persons |pdf=|usr=}}
@@ Zeile 239: / Zeile 226: @@
-{{tp|p=32300796|t=ä. A geroscience perspective on COVID-19 mortality |pdf=|usr=}}
-{{tp|p=32279081|t=ä. Clinical characteristics and outcomes of older patients with coronavirus disease  2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study |pdf=|usr=}}
 {{tp|p=32360995|t=ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease |pdf=|usr=}}
 {{tp|p=32278005|t=ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study |pdf=|usr=}}
@@ Zeile 247: / Zeile 232: @@
 {{tp|p=32305291|t=ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury |pdf=|usr=}}
-{{tp|p=32240670|t=2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up |pdf=|usr=}}
-{{tp|p=32171866|t=ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients |pdf=|usr=}}
@@ Zeile 259: / Zeile 243: @@
 {{tp|p=32147409|t=ä. Are children less susceptible to COVID-19?|pdf=|usr=}}
-{{tp|p=32366317|t=2020. Covid-19?The real role of NSAIDs in Italy |pdf=|usr=}}
-{{tp|p=32306369|t=ä. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities |pdf=|usr=}}
 {{tp|p=32335513|t=2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis |pdf=|usr=}}
 {{ttp|p=32335512|t=2020. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs |pdf=|usr=}}
-{{tp|p=32373791|t=ä. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected?|pdf=|usr=}}
-{{tp|p=32302293|t=2020. COVID-19 in older adults: clinical, psychosocial, and public health considerations |pdf=|usr=}
@@ Zeile 276: / Zeile 258: @@
-{{tp|p=32278370|t=2020. The gendered dimensions of COVID-19 |pdf=|usr=}}
 {{tp|p=32334645|t=2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection |pdf=|usr=}}
@@ Zeile 289: / Zeile 273: @@
 {{tp|p=32332856|t=ä. COVID-19 in persons with haematological cancers |pdf=|usr=}}
-{{tp|p=32353398|t=ä. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China |pdf=|usr=}}
 {{tp|p=32344304|t=ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?|pdf=|usr=}}
 {{tp|p=32339776|t=2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease |pdf=|usr=}}
@@ Zeile 344: / Zeile 328: @@
-{{tp|p=32372822|t=2020. Why are ethnic minorities worse affected?|pdf=|usr=}}
-{{tp|p=32372818|t=2020. Men hit harder by covid-19 |pdf=|usr=}}
 {{tp|p=32372803|t=2020. Children and covid-19 |pdf=|usr=}}
 {{tp|p=32243722|t=2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection |pdf=|usr=}}
-{{tp|p=32360482|t=2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?|pdf=|usr=}}
-{{tp|p=32343745|t=2020. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients |pdf=|usr=}}
 {{tp|p=32231171|t=2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis |pdf=|usr=}}
-{{tp|p=32343807|t=ä. The Elderly & COVID-19: Cocooning or Culling: - the choice is ours |pdf=|usr=}}
 {{tp|p=32289171|t=ä. Cardiac drugs and outcome in COVID-19: Reply |pdf=|usr=}}
 {{tp|p=32289168|t=ä. Cardiac drugs and outcome in COVID - 19 |pdf=|usr=}}
-{{tp|p=C7129713|t=ä. Coronavirus: la emergencia geri�trica de 2020  Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a |pdf=|usr=}}
-{{tp|p=32377677|t=ä. COVID-19 in Older People: A Rapid Clinical Review |pdf=|usr=}}
 {{tp|p=32228252|t=2020. COVID-19, ACE2, and the cardiovascular consequences |pdf=|usr=}}
@@ Zeile 391: / Zeile 375: @@
 {{tp|p=32243894|t=2020. COVID-19 infection in cancer patients: early observations and unanswered questions |pdf=|usr=}}
 {{tp|p=32224151|t=2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China |pdf=|usr=}}
-{{tp|p=32321720|t=2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) |pdf=|usr=}}
 {{tp|p=32245656|t=2020. COVID-19 in patients with cardiovascular diseases |pdf=|usr=}}
@@ Zeile 397: / Zeile 381: @@
-{{tp|p=32220865|t=2020. Non-steroidal anti-inflammatory drugs and covid-19 |pdf=|usr=}}
-{{tp|p=32205306|t=2020. Covid-19: European drugs agency to review safety of ibuprofen |pdf=|usr=}}
-{{tp|p=32184201|t=2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists |pdf=|usr=}}
-{{tp|p=32253225|t=2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected  cases |pdf=|usr=}}
-{{tp|p=32291262|t=2020. Covid-19: Black people and other minorities are hardest hit in US |pdf=|usr=}}
 {{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected  with SARS-CoV-2 |pdf=|usr=}}
 {{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
@@ Zeile 428: / Zeile 408: @@
-{{tp|p=32374012|t=2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries |pdf=|usr=}}
 {{tp|p=32376408|t=ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study |pdf=|usr=}}
@@ Zeile 438: / Zeile 418: @@
 {{tp|p=32329083|t=2020. (ang.)COVID-19 transmission through host cell directed network of GPCR |pdf=|usr=}}
-{{tp|p=32234728|t=2020. EMA advice on the use of NSAIDs for Covid-19 |pdf=|usr=}}
@@ Zeile 454: / Zeile 434: @@
 {{tp|p=32310015|t=2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature |pdf=|usr=}}
-{{tp|p=32255507|t=2020. COVID-19 and Older Adults: What We Know |pdf=|usr=}}
 {{tp|p=32376098|t=ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS |pdf=|usr=}}
-{{tp|p=32253888|t=2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection |pdf=|usr=}}
@@ Zeile 512: / Zeile 492: @@
-{{tp|p=32302282|t=2020. Sex- and Gender-specific Observations and Implications for COVID-19 |pdf=|usr=}}
-{{tp|p=C7149289|t=2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19 |pdf=|usr=}}
 {{tp|p=C7187739|t=ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa |pdf=|usr=}}
-{{tp|p=32430225|t=ä. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income |pdf=|usr=}}
@@ Zeile 543: / Zeile 523: @@
 {{tp|p=32376408|t=ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study |pdf=|usr=}}
-{{tp|p=C7128941|t=2020. COVID19 Presents High Risk to Older Persons |pdf=|usr=}}
 {{tp|p=32376043|t=ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak |pdf=|usr=}}
 {{tp|p=32380288|t=ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans |pdf=|usr=}}
@@ Zeile 568: / Zeile 548: @@
 {{tp|p=32389584|t=ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis |pdf=|usr=}}
-{{tp|p=32292226|t=ä. Coronavirus: la emergencia geriatrica de 2020...|pdf=|usr=}}
-{{tp|p=32418728|t=ä. Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection |pdf=|usr=}}